Avidity Biosciences, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of RNA for the last quarter is 2.34 M USD, and it's 14.23% higher compared to the previous quarter. The net income of Q3 24 is -80.40 M USD.